Delivery Order 36F79721D0050-36C24722F0617
- This is a federal contract award to CDX Diagnostics, Inc., doing business as Oral Scan Laboratories, for WATS 3D diagnostic services for the Portland VA Medical Center. The contract is a $34,787.60 firm fixed-price delivery order under CDX Diagnostics' Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract with the General Services Administration (GSA Schedule 621-II). The contract has an ultimate completion date of September 30, 2027. CDX Diagnostics is a for-profit...
- This is a federal contract award to CDX Diagnostics, Inc., a self-certified small disadvantaged business, for WATS 3D testing services. The contract was awarded by the U.S. Department of Veterans Affairs, Veterans Integrated Service Network 17, under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract (FSS-621-II). The contract has a ceiling value of $3,548.76 and a period of performance through May 31, 2026. CDX Diagnostics provides specialized oral pathology...
- CDX Diagnostics, Inc., doing business as Oral Scan Laboratories, has been awarded a $210,127.68 firm fixed price delivery order against the Medical Laboratory Testing and Analysis Services Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7. This delivery order is for TCGRX unit dose medication packager services to be performed in Durham, North Carolina by September 6, 2022. The contract was awarded on August 6,...
- Exact Sciences Corporation, through its Exact Sciences Laboratories, LLC division, was awarded a $123,666.64 firm fixed-price delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 20 for reference laboratory services, with an ultimate completion date of June 30, 2027. This delivery order was issued without a set-aside designation and is performed under the Medical Laboratory Testing and Analysis Services (FSS-621-II) Federal Supply Schedule, through which VA...
- MDxHealth, Inc. has been awarded a $66,501.87 delivery order under a Blanket Purchase Agreement call for prostate cancer testing services, designated as "Prostate Cancer Test – Option Two." This Firm Fixed Price contract, issued on July 1, 2024, with an ultimate completion date of March 6, 2026, represents a call against MDxHealth's existing $755,655 BPA with Veterans Integrated Service Network 8, which operates under the General Services Administration's Medical Laboratory Testing and...
- Exact Sciences Corporation, through its Exact Sciences Laboratories, LLC division, was awarded a delivery order on October 1, 2022, valued at $203,932.36 for Oncotype DX testing services to support the Department of Veterans Affairs' Veterans Integrated Service Network 7 (VISN 7). The contract, which will be completed by July 31, 2027, operates under a firm fixed-price arrangement with no set-aside designation, enabling VISN 7 to procure specialized genomic testing services at a competitive...
- This federal contract is for the provision of prostate cancer diagnostic testing services by Mdxhealth, Inc. to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration's Veterans Integrated Service Network (VISN) 8. The contract has a period of performance from October 1, 2020 to September 20, 2021, with a completion date of March 31, 2022. It is a firm fixed price delivery order issued under Mdxhealth's existing General Services Administration (GSA) Federal Supply Schedule...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 17 (VISN 17), awarded Mdxhealth, Inc. a $27,657.57 firm fixed-price blanket purchase agreement call for DX Prostate Testing services. The award, issued on April 3, 2025, with an ultimate completion date of April 2, 2026, represents a delivery order under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). Mdxhealth, a for-profit molecular diagnostic company headquartered in Irvine,...
- This is a firm fixed price delivery order for Oncotype DX testing services awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network (VISN) 8 to Exact Sciences Corp, Exact Sciences Laboratories, LLC Division. The award has a potential value of $385,859.34 and a completion date of March 31, 2022. The contract was placed under the Medical Laboratory Testing and Analysis Services Multiple Award Schedule (FSS-621-II) contract. No...
- Exosome Diagnostics Inc., a Bio-Techne Corporation subsidiary based in Waltham, Massachusetts, received a delivery order award from Veterans Integrated Service Network (VISN) 7 on April 1, 2021, for its ExoDx Prostate (IntelliScore) diagnostic testing services. The delivery order, valued at $438,951.68 on a firm fixed-price basis, is issued under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) and does not utilize a set-aside designation. Performance...
- Medical Laboratory Testing and Analysis Services (FSS-621-II)Master GSA Schedule
- 36F79721D0050Federal Supply Schedule
- 36F79721D0050-36C24722F0617Delivery Order
CDX Diagnostics, Inc. (doing business as Oral Scan Laboratories) was awarded a delivery order valued at $61,747.99 for WATS3D testing services under a Total Small Business set-aside. The award, issued on August 5, 2022, with an ultimate completion date of August 4, 2027, supports the Veterans Integrated Service Network 7 (VISN 7), a component of the Department of Veterans Affairs. The work will be performed in Augusta, Georgia. This delivery order falls under CDX Diagnostics' existing General Services Administration Schedule contract for Medical Laboratory Testing and Analysis Services (FSS-621-II), which enables VA healthcare networks to access specialized oral pathology testing services on a firm fixed-price basis. CDX Diagnostics provides WATS3D surveillance and screening testing for conditions such as Barrett's Esophagus and other oral pathology conditions to support VA healthcare facilities and networks nationwide. The company operates testing services out of its San Antonio facility and has established a track record of federal contracts totaling over $800,000 with VA Medical Centers across multiple states, including New York, North Carolina, Georgia, and Texas. The parent GSA Schedule contract under which this delivery order was issued has a potential value exceeding $1 million with a period of performance through December 2025, positioning CDX Diagnostics as a key provider of specialized oral pathology testing services to the Veterans Health Administration.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00007 | Exercise an Option | $26.1k | 3/30/26 | |
| P00006 | Funding Only Action | ($52k) | 11/17/25 | |
| P00005 | Exercise an Option | $52.2k | 7/1/25 | |
| P00004 | Other Administrative Action | ($48k) | 10/8/24 | |
| P00003 | Exercise an Option | $52.2k | 5/23/24 |